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ABSTRACT 
Quality of life (QoL) has a weak relationship with lung function (LF) impairment in COPD; some cope well 
despite poor LF, while others suffer disproportionate QoL impairment despite well-preserved LF. Adjuvant non-
pharmacological interventions such as rehabilitation and psychological/behavioural support may help if 
acceptable and targeted appropriately, but are under-used and sometimes declined by patients. This study aimed 
to explore and understand variations in experiences and coping strategies in patients with different severities of 
disease and disease-specific QoL. Thirty four participants were purposively sampled across a spectrum of LF 
and QoL impairment, to cover a grid of sub-groups (‘very severe LF, good QoL’, moderate LF, poor QoL’ etc.). 
Semi-structured interviews, digitally recorded, were analysed by thematic analysis. Data saturation was 
achieved.  Four themes emerged: symptom impact, coping strategies, coping challenges, support needs. Most 
described employing multiple coping strategies yet over half reported significant challenges coping with COPD 
including: psychological impact, non-acceptance of diagnosis and/or disease progression, effects of co-
morbidities and inadequate self-management skills. Approximately half wanted further help, ideally non-
pharmacological, across all LF impairment groups but mainly with lower QoL. Those with lower QoL 
additionally reported greater psychological distress and greater use of non-pharmacological support strategies 
where accessible. Patients who develop effective coping strategies, have better quality of life independent of 
objective LF, whereas others cope poorly, are aware of this, and report more use of non-pharmacological 
approaches. This study suggests that severely impaired QoL, irrelevant of lung function, is a powerful patient 
centred indication to explore the positive benefits of psychological and behavioural support for distressed COPD 
patients.  
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Introduction 
COPD is a major cause of morbidity and mortality, currently is the fifth leading cause of death in the UK and  
predicted to become the third leading cause of death worldwide by 20201.  Most patients are managed in 
primary care2 accounting for 4% - 10% of GP consultations in the UK3. Treatment aims are to improve 
symptoms and health related quality of life (HRQoL) while minimising further damage and complications, 
exacerbations and hospital admissions.  It is a complex, multifaceted disease with both somatic and affective 
components. Anxiety and depression are common4 and psychological comorbidity associated with poor 
outcomes including impaired functional status5;6,  HRQoL7-9 and worsened prognosis10. However, psychological 
comorbidity is frequently unrecognised and untreated11;12 which has potential implications for treatment 
compliance and health system outcomes such as hospital admissions and primary care consultation rates 6;11;13.  
As an incurable chronic disease, improving HRQoL is a major aim of COPD management14-21. Prognosis has 
been shown to be related to HRQoL22;23.  The UK Department of Health Strategy for COPD24 highlights the 
need to recognise and address HRQoL impairment and psychological comorbidity. However, due to a lack of 
clinical trials there is currently a paucity of evidence on the most effective strategies to identify and address 
psychological comorbidity in COPD, or on targeting these interventions to specific patient groups.  
The relationship between physiological disease impairment (as measured by percentage predicted forced 
expiratory volume in the first second, FEV1) and patients’ disease experience21 is weak.  Some patients have 
very impaired HRQoL despite relatively minor lung function impairment and others have good HRQoL despite 
severe lung function impairment. It is likely that psychological and behavioural factors may be relevant25-27, but 
the coping strategies used by patients and their relationship to individual psychological factors have been 
incompletely explored. This qualitative study aimed to explore and understand variations in experiences and 
coping strategies in COPD patients across different severities of disease and disease impact.  
RESULTS 
Participant characteristics 
Thirty-four participants were interviewed across the differing severities of disease severity and HRQoL (Figure 
1). Table 1 reports their characteristics. The mean interview length was 110 minutes (range 55-150); 3 
interviews were terminated early due to poor health (breathlessness and/or fatigue). 
Findings 
4 
 
Four themes were identified. Sub-analysis exploring subgroup differences (between and within categories of 
disease severity and disease impact) are reported in the text at the end of each theme; Figure 1 highlights the key 
sub-group differences identified; further details are reported in Appendix 1 in Supplementary information. 
THEME 1: SYMPTOMS AND IMPACT 
All but two described breathlessness, with other common symptoms being chest infections, cough, wheeze, 
fatigue and sleep disturbance.  Those with more physiologically severe disease reported more frequent 
exacerbations and hospitalisation. Disease impact varied considerably, ranging from minimal or variable to 
severe impact, with major restrictions to daily life, with some requiring assistance with personal care and 
mobility aids.  As dictated by the sampling matrix, the data confirmed a high degree of variability in COPD 
impact both within and between physiological severities. Although generally those with worse lung function 
tended to report more severe symptoms and impact, a high level of variability was noted, with some reporting 
low impact and active lives despite severely damaged lungs, and others reporting severe impact despite well 
preserved lung function. For example, two participants having the same GOLD classification (stage 4, very 
severe) reported experiencing completely different lives. Participant 17 explained how COPD significantly 
curtailed basic daily activities such as dressing,  
I'm quite sedentary. But I find just getting up in the morning and going to the bathroom, go to the toilet, 
have a wash, comb my hair, have a shower or whatever, clean my teeth, I have to go back and sit on 
the bed and get my breath back just from doing that. Just from putting my shoes on in the morning, 
even that can make me breathless.[ID17] 
whilst Participant 31 was enjoying active hobbies of sailing and dog walking. 
I still go sailing every week. I've still got a boat to play with... It just gets harder! ….every day normally, 
just walking the dogs and messing about like I do. Don't forget in between time I've got to cook for 
myself as well. [ID31] 
In contrast, some participants with milder disease reported COPD as significantly affecting their life. 
Yes, terrible breathing problems. I can't walk any distance without getting out of breath. .. I have a 
buggy for when I shop, but I'm tempted to get one of those wheeler things so as I can get my exercise, 
because I just sit and sit and sit, you know. It's silly… because I can't breathe I can't do the exercise 
and I can't do nothing [ID27] 
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THEME 2: COPING STRATEGIES  
A range of coping strategies were used, with most participants using more than one approach.  
Medication 
Nearly all participants used prescribed medication for COPD.  Most considered their medication effective but 
four participants found their inhalers ineffective of difficult to use when breathless. Eight participants managed 
COPD with medication alone. 
Non-pharmacological coping strategies 
Twenty six participants reported using a variety of additional coping strategies.  Ten had attended pulmonary 
rehabilitation (PR) reporting the information, exercises and breathing training helpful.  
I've been on a COPD course for exercising with physiotherapists, there was a group of us, we could all 
chat together with our different problems and how we dealt with it. That was brilliant. That was a six 
week course. We were all sorry it ended. It was very good. [ID14] 
Fourteen reported exercising regularly, either continuing PR exercises or using other forms of exercise e.g. 
walking daily. All perceived regular exercise helped them maintain their wellbeing or reduced medication 
reliance. Breathing exercises learnt either at PR, yoga or relaxation classes, swimming or singing lessons, were 
also helpful. 
If I get stressed I try and control it [breathlessness]. I'll say, 'Right, just sit down and think about this. 
What's happening here? You're breathing in', [inhales loudly] and I do the three breaths. It sort of 
comes back to you.  [ID29] 
Other used complementary and alternative medicine (CAM) such as Reiki, osteopathy, salt pipes and some also 
explored psychological approaches by visiting therapists managing depression/ anxiety [hypnotherapy, cognitive 
behavioural therapy (CBT), relaxation, counselling), with varying effectiveness. Activity avoidance and limiting 
exercise to reduce dyspnoea was used by some.  
I have to think what I'm going to do and how much breath I'm going to need to do it, so I'm 
permanently thinking about it…. else I could end up in trouble,[ID28] 
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Others made practical adjustments including the use of mobility aids, stair lifts, and assistance with personal 
care and/or housework. A single participant attended a Breathe Easy (British Lung Foundation) patient support 
group.  
Some subgroup differences were identified predicting multiple or specific types of strategies (Figure 2). Whilst 
most used more than one modality, seven participants were using three or more approaches, principally those 
with more severe physiological disease. Those with ≥severe disease were more likely to have attended PR, 
regularly exercise and use pacing. Those with ≥high QoL impairment were generally more likely to seek CAM 
or psychological treatments.   
Mental/Behavioural coping strategies 
Nearly all participants described one or more mental or behavioural coping strategies.  ‘Taking control of COPD’ 
was an effective mechanism for those who could achieve it. These patients were determined that COPD would 
not control their life, continuing an active life with hobbies and interests despite physical limitations .  
I try and do as much as I can and what I can - while I can; I will not let it defeat me. .. No way. I want 
to be able to, you know, keep my quality of life going …. that's my motto. [ID3] 
Ways of enabling taking control included accepting their diagnosis and consequent limitations, having a realistic 
disease understanding and cultivating a rational, rather than emotional response to the disease ;  
I already have got my own controls with it and I never get anxious…. It's better to stay calm and 
address the situation and quantify it and go along with the way that you think you should.. [ID11] 
Other coping strategies reported also included maintaining emotional positivity despite symptoms,  
I've got a good mindset and I don't let anything get me down really….generally speaking every day is a 
bonus for everybody really and I try and make the most of it. I have a car so I get out and then I can do 
my walking…[ ID11] 
as well as the use of ‘distraction’ and  stress avoidance  
I just try and take my mind off it by reading. I might watch some telly. …. listening to my music. Just 
things to try and take my mind of it... Yes, that's my way of coping with it really. [ID14] 
Finally ‘minimising’  their disease by refusing to perceive themselves as ill, or by viewing the impact of COPD 
as relatively minor in comparison to other illnesses was used by some . 
7 
 
My inability to walk [because of a spinal condition] affects me a lot… it starts getting painful after 
about 50 yards and after 200 yards I really need to sit down. ..[the COPD] doesn't affect me. Most of 
the time, I mean I should think probably two weeks a year I'm conscious of it.[ID5] 
Sub group analysis identified using a ‘minimising’ strategy was associated with lower QoL impairment, whilst 
those who used distraction to cope generally had highly impaired QoL (Figure 2). 
THEME 3: COPING CHALLENGES  
Nineteen participants were still struggling to cope with COPD either intermittently or persistently (Figure 2). 
Although most participants had co-morbidity, eleven reported having multiple conditions was challenging.  
Yes, the coughing, breathlessness, it affects my diabetes, … diabetes causes infections and then they 
live off infections, the sugar, and so I do tend to get a lot of infections [ID14] 
Being depressed and/or anxious was also common with six receiving treatment. Most attributed COPD as a 
cause and/or trigger for their depression/anxiety, and many of these had high HRQoL impairment relative to 
lung function.  Anxiety, reported by thirteen participants, was associated with being breathlessness   
I've choked a few times, and I know what it's like, and it's quite frightening. So, yes, it is one of my 
biggest fears, is not being able to breathe. [ID13] 
For some, their anxiety significantly restricted their lives, with three reporting severe anxiety, panic attacks and 
agoraphobia.  
As I started to get older I started to get worse and the phlegm started to build up on my chest. .. you 
have some very dodgy moments through the course of the day. And, that's when I started to really go 
downhill because I couldn't breathe…it put me in [a] fear state really because I didn't want to leave my 
nebuliser, because the nebuliser was the only thing that brought me round. ... I had to have that 
nebuliser.., I had … about three years basically, really bad years. ..I didn't go out. [ID34] 
Twelve reported being depressed of which five participants were taking antidepressant medication, two referred 
for psychological therapies and another two had independently tried meditation. Depression was viewed as a 
response to the limitations imposed by COPD.   
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Well it [COPD] stops me doing things. It stops me gardening and it bothers me that way. I get 
frustrated with not being able to do things. .... I've adapted to it now .. I don't do anything full stop.. 
[ID 32] 
Some were still unable to accept their diagnosis.   
I still don't accept it…it's accepting, and accepting and moving on from it. Because that's what causes, 
it's the main factor in the depression. It is accepting and knowing my limitations. Helping, somebody to 
help me to accept that that's what's happening ... I know the cough's there. I know I've got COPD, but 
that doesn't mean to say I'm going to accept it.[ID10] 
Others reported a sense of loss of wellness, a struggle to adjust and a feeling of being a burden on friends, 
family and doctors.    
I decided to take early retirement. So I retired just before .. I was 64. And, [pause] you know the 
general idea was to do a bit of travelling... But it's restricted all that. So, all my dreams of what I was 
going to do faded away basically because of my lungs [ID34] 
Perceived lack of medical support also made coping challenging. Some felt stigmatised and blamed for having a 
smoking-related disease. Deteriorating disease was additionally challenging practically and emotionally.  
It's at the stage where they can do nothing for me now. The last appointment I had with the specialist 
they wrote me off. … they won't contact me anymore because there's nothing else they can do. It's a 
case of right that's it, yeah, on your bike. [ID32] 
Participants who perceived COPD as particularly challenging had a range of physiological severities but 
generally had lower QoL and included most of those self-reporting depression and/or anxiety (Figure 2). 
THEME 4: SUPPORT NEEDS 
Over half expressed a need and a desire for additional help with their breathing. Most understood the 
progressive nature of COPD, but had differing expectations about what further help could achieve. Some aspired 
to a cure despite recognising this was unrealistic.  
I just want them to find something, do something about it and get me back to normal. That's all I want. 
[ID20] 
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Although some did not expect anything could help, most wanted interventions to help their breathing, 
particularly those participants with greater psychological disturbance and impaired QoL. Many wanted 
symptoms improvement, although most were reluctant to take further medication, generally expressing a 
preference for psychological support  
For me it's acceptance. It's not the cough. It's not anything, it's accepting, and accepting and moving 
on from it. Because that's what causes, it's the main factor in the depression.[ID10] 
or non-pharmacological treatments.   
  I take enough [tablets] as it is, I don't want any more. [ID6]  
The majority of those desiring further help had high QoL impact (Figure 2) and nearly all participants wanting 
help were also those reporting significant psychological impact from COPD.  
DISCUSSION 
Main findings 
In this qualitative study we specifically utilised a stratified sampling strategy to investigate the variation in 
individual experience and range of coping strategies used by patients with differing degrees of physiological 
lung damage and quality of life impairment. This novel approach ensured we collected data from people with 
the same level of lung function but with varying experience of quality of life  in order to make qualitative 
comparisons to gain insight into what personal and interventional strategies are helpful to patients. Most of our 
sample were using medication and employed often multiple coping strategies either self-directed or supported 
by external interventions, such as pulmonary rehabilitation. Yet for some, significant symptoms and lifestyle 
impact remained. Our key finding is that roughly half of the sample seemed to have managed to become 
relatively well adjusted to their on-going health impairment and were ‘making the best’ of life within the 
constraints of their condition. These individuals had adopted positive coping strategies that supported them in 
their desire to get on with an active and involved life.  Unfortunately, the other half of our sample were having a 
much poorer quality of life which seem to be driven by maladaptation to their on-going disease and the 
consequent behavioural, psychological and emotional dysfunction. Their coping strategies, such as activity 
limitation by ‘pacing’,  distraction, and using psychological therapies and CAM appear to be less effective, and 
this group was characterised by much greater reporting of COPD-associated anxiety and depression. This group 
were aware that things were not going well for them, and conceded they needed help. They appeared willing to 
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engage in interventions that could potentially help them further, particularly non-pharmacological interventions 
such as psychological and behavioural support. 
 
Interpretation of findings in relation to previously published work 
Mirroring previous literature, we identified similar strategies that the participants employed in coping with 
living with COPD namely the use of non-pharmacological interventions including CAM32;33  and psychological 
approaches, as well as mental and behavioural strategies such as pacing. Similarly we also identified previously 
documented challenges impairing coping34 including managing co-morbidities34;35, lacking self-management 
skills36, depression, anxiety35-38. Whilst quantitative data on the disparity between physiological severity and 
quality of life have previously been reported21 this novel study provides the first depth exploration of patients 
disease experiences underpinning this observation and includes a characterisation of a sub-group of patients 
with unmet needs. Our data suggests that the in/effectiveness of coping strategies may in part mediate their 
quality of life but this domain is not currently addressed  in HRQoL measures39.  
 
Strengths and limitations of this study 
There were some limitations to this study. Participants were purposively recruited using a maximum variation 
sample across physiological severities and HRQoL impairment for a wider study on perspectives of a non-
pharmacological intervention; as such recruited participants may have been more engaged than the broader 
community. We had some difficulty recruiting patients with the most severe LF impairment. The strengths were 
that data saturation was achieved, including for all sub-group analysis including very severe LF. A range of 
standard approaches to minimise bias were used, including a detailed audit trail, undertaking negative and 
deviant case analysis; cross checking of coding strategies and a multi-disciplinary research team including 
Patient and Public Involvement input from COPD patients. 
 
Implications for future research, policy and practice 
This qualitative hypothesis generating study has identified potential future research questions. We feel that 
targeted interventional studies designed to improve self-management and coping strategies using non-
pharmacological approaches for appropriately characterised patients are needed. There is currently an 
inadequate evidence base for most non-pharmacological interventions (other than PR) in COPD40;41, and in 
particular for psychological and behavioural interventions. Our data suggest that such studies are likely to be 
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attractive and may plausibly be effective in an identifiable sub-group of patients who appear willing to consider 
adopting them. This group can be identified by those with poor quality of life, as assessed by a disease-specific 
health status instrument, regardless of physiological severity who also self-report COPD related depression 
and/or anxiety. We feel this characterisation identifies a COPD ‘phenotype’ who should be targeted by such 
studies, rather than groups defined by the lung function (FEV1) or even breathlessness [MRC dyspnoea scale42] 
criteria that are currently used to stratify patients for interventions e.g. PR programmes. 
Conclusions 
In summary, our study provides a novel perspective on patients’ experience of living and coping with COPD. 
The data suggests that the mismatch previously described between QoL and objective LF in COPD may be 
mediated, at least in part by, by variations in the effectiveness of the individual’s personal coping and self-
management strategies which can negatively impact on quality of life. This group, who have the most to gain 
from psychological and behavioural support interventions, are also likely to be receptive to such interventions. 
This study suggests that severely impaired QoL, irrespective of lung function, is a powerful patient centred 
indication to explore the positive benefits of psychological and behavioural support for distressed COPD 
patients.  
METHODS 
Design: Qualitative study of individual face-to-face semi-structured interviews analysed by thematic analysis 
28;29.  
Sampling and recruitment  
Patients with a physician confirmed COPD and quality-assured spirometry readings (to permit physiological 
impairment categorisation) and COPD disease-specific QoL assessments using the validated COPD Assessment 
Test, CAT,30 were recruited from primary and secondary care sites and a patient volunteer database in South 
England. Participants were purposively sampled to constitute a maximum variation sample across all severities 
of physiological disease [mild to very severe lung function impairment using GOLD classification31) and 
disease specific quality of life (low to very high disease impact using the CAT); Figure 1. Potential participants 
were identified based on physiological disease severity (recent percentage predicted FEV1) and screened by 
telephone using CAT30. Those fitting the planned sampling matrix were invited to interview.  729 people with 
COPD were approached, 136 (18.4%) responded and were telephone screened, 36 were recruited and 34 were 
interviewed (2 dropped out for health reasons). 
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Data collection 
Interviews were conducted by SB (from 12/2013 - 04/2014) generally in the participants home. Written 
informed consent was obtained prior to interview. The topic guide explored: experience of symptoms and 
perceived impact; managing COPD; challenges; perceived need for additional support. Interviews were 
conducted until data saturation was achieved. Interviews were digitally recorded and transcribed verbatim for 
textual analysis using pseudonyms. Reflexive notes, completed after each interview, aided analysis. Ethical 
approval was obtained from the East Midlands Research Ethics Committee (REC) (13/EM/0315) and 
sponsorship from the host institution.  
Data analysis 
Interviews were imported into Atlas.ti v5.2 for coding and thematic analysis28;29.   Analysis was conducted both 
within and across individual interviews to identify group similarities and differences including negative and 
deviant case analysis.  Interviews were analysed line by line using open coding and then grouped into themes 
and subthemes encapsulating all participants’ experiences. Sub-group analysis was conducted to explore any 
differences across severities of disease severity and QoL impairment. Analysis confirmed saturation was 
achieved (including exploring sub-group differences) with no new findings identified after 32 interviews.  
Illustrative quotations from the interviews describing the themes and subthemes (in italics) are reported in the 
text.  
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Figure 1.  Participants’ recruitment sampling grid 
 
a Disease impact assessed by COPD Assessment Test(30) 
b Disease severity per GOLD classification(31) 
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Figure 2: Diagrammatic representation of sub-group analysis   
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